Stanpacks(India) (530931)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 1.06 implies market cap of ₹7 Cr is close to book value of ~₹6.6 Cr, providing some downside cushion if assets are sound
• ROCE of 7% shows the asset base can generate positive operating returns, even if net earnings are negligible
• Price-to-sales ratio is roughly 0.3x based on annualized sales of ₹24 Cr (₹6 Cr quarterly), which is optically inexpensive
• 52-week range of ₹9.10-₹15.75 suggests the stock has held above ₹9, indicating possible market support

Concerns

• Net profit is near zero with profit growth of -250%, leaving P/E undefined and no earnings to justify valuation
• Sales declined 7.49% year-on-year, signaling shrinking business activity or lost customers
• Piotroski F-Score of 3/9 points to weak fundamentals, potential margin pressure, and financial fragility
• No dividend, and missing promoter holding and debt/equity disclosures make it impossible to assess insider commitment and leverage risk

AI Analysis

Let me look at Stanpacks. At ₹11.55, this micro-cap packaging firm commands a market cap of just ₹7 Cr. The first thing I notice is that the business is not earning anything—net profit is near zero and profit growth has cratered by 250%. Sales are shrinking at 7.49% annually. This is not a great business. Packaging is a commodity-like industry, and I see no moat here, no pricing power, no brand. Return on equity is essentially zero, though return on capital employed is 7%, which suggests the assets generate some operating income, but after financing or other costs, nothing reaches the bottom line. The balance sheet is the only possible attraction. Book value stands at ₹10.92, and shares trade at 1.06 times that. In a liquidation, maybe you'd get most of your money back if the assets are honestly valued. But I'm skeptical. The Piotroski F-Score is 3 out of 9, which indicates weak fundamentals—poor profitability, declining margins, and likely rising red flags. No dividend, and the promoter holding and debt-equity data are missing. I cannot trust what I cannot see. A 0.3 times sales valuation looks cheap on the surface, but a company that loses money and shrinks can erode that book value quickly. This is not a wonderful business at a fair price; it's a mediocre business at a possibly fair price. I'd compare it to a cigar butt: a puff or two might be left, but I'd rather wait for a clearer margin of safety. If book value is solid and operations can stabilize, there could be a turnaround—but the numbers today don't justify that conclusion. I'd watch for several quarters of stable sales and positive net profits before even thinking of investing. This is an asset play, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer